GLOBAL SEPSIS DIAGNOSTICS MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

GLOBAL SEPSIS DIAGNOSTICS MARKET 2021-2028

Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per the detailed analysis of the global sepsis diagnostics market by Triton Market Research, the market, in terms of revenue, is estimated to grow at a CAGR of 8.18% during the forecasting years 2021-2028. The market gained $605.0 million in 2020, and is expected to acquire revenue worth $900.7 million by 2028.


Report scope can be customized per your requirements. Request For Customization

Sepsis is a condition that arises due to the body’s response to pathogenic microorganisms in the blood. Sepsis cognizance has considerably increased over the past five years. However, the management of sepsis still faces numerous unmet medical needs. Therefore, several multinational companies like Roche and Siemens Healthineers undertake initiatives to raise awareness and develop novel technologies to address these issues.

According to the World Health Organization (WHO), sepsis’s global epidemiological burden is difficult to ascertain. It is expected to affect more than 30 million people worldwide, possibly leading to 6 million deaths each year. Besides, one in ten deaths associated with pregnancy and childbirth is due to maternal sepsis. In the people affected with COVID-19 sepsis, the virus is the infection. The life-threatening organ dysfunction includes the lungs, brain, kidneys, heart, and liver. All these factors are contributing to the growth of the Sepsis Diagnostics market.

Triton’s report aims to get an overview of the sepsis diagnostics market in terms of various factors. Within this report, the key insight and the market summary regarding the market have been discussed. Also, the Impact of COVID-19 on the market, Porter’s five forces model, market attractiveness matrix, vendor scorecard, and key market strategies have been studied in detail.

Market drivers such as the rise in hospital-acquired infections among patients and increased sepsis prevalence are driving the studied market’s growth. Additionally, the growth opportunities in the emerging economies and rising government initiatives for research activities related to sepsis can be leveraged by the market to reach its projected growth.

However, major restraints like the high cost associated with the instrument and reimbursement issues are obstructing the global market’s future growth.



Key geographies covered in the sepsis diagnostics market are:

•           North America: Canada and United States

•           Europe: Russia, Spain, United Kingdom, Germany, France, Italy, and Rest of Europe

•           Asia-Pacific: Australia & New Zealand, Japan, India, ASEAN countries, South Korea, China, and Rest of Asia-Pacific

•           Latin America: Mexico, Brazil, and Rest of Latin America

•           Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa

The segmentation analysis of the sepsis diagnostics market includes:

•           Market by Technology:

           o          Microbiology

           o          Immunoassay

           o          Molecular Diagnostics

           o          Other Technologies

•           Market by Diagnostic Method:

           o          Conventional Diagnostics

           o          Automated Diagnostics

•           Market by Product:

           o          Blood Culture Media

           o          Assay Kits & Reagents

           o          Instruments

•           Market by Pathogen:

           o          Gram-Positive and Gram-Negative Bacterial Sepsis

           o          Fungal Sepsis

           o          Other Pathogens

•           Market by Testing Type:

           o          Laboratory Testing

           o          Point-of-Care Testing

The distinguished players engaged in the sepsis diagnostics market are EKF Diagnostics, Biomerieux SA, Response Biomedical Corporation, Abbott Laboratories, Luminex Corporation, Thermo Fisher Scientific Inc, Cytosorbents, Becton Dickinson and Company (CR Bard), F Hoffmann-La Roche, T2 Biosystems Inc, Bruker Corporation, Immunexpress Inc, and Danaher Corporation.  

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL SEPSIS DIAGNOSTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET

2.2. KEY INSIGHTS

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. CONTRACTS AND PARTNERSHIP

2.6.2. BUSINESS EXPANSION AND DIVESTITURES

2.6.3. ACQUISITIONS & MERGERS

2.6.4. NEW PRODUCT LAUNCHES

2.7. MARKET DRIVERS

2.7.1. RISE IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS

2.7.2. INCREASED PREVALENCE OF SEPSIS

2.8. MARKET RESTRAINTS

2.8.1. HIGH COST ASSOCIATED WITH THE INSTRUMENT

2.8.2. REIMBURSEMENT ISSUES

2.9. MARKET OPPORTUNITIES

2.9.1. GROWTH OPPORTUNITIES IN THE EMERGING ECONOMIES

2.9.2. RISING GOVERNMENT INITIATIVES FOR RESEARCH ACTIVITIES RELATED TO SEPSIS

3. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY

3.1. MICROBIOLOGY

3.2. IMMUNOASSAY

3.3. MOLECULAR DIAGNOSTICS

3.4. OTHER TECHNOLOGIES

4. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD

4.1. CONVENTIONAL DIAGNOSTICS

4.2. AUTOMATED DIAGNOSTICS

5. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY PRODUCT

5.1. BLOOD CULTURE MEDIA

5.2. ASSAY KITS & REAGENTS

5.3. INSTRUMENTS

6. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN

6.1. GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS

6.2. FUNGAL SEPSIS

6.3. OTHER PATHOGENS

7. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE

7.1. LABORATORY TESTING

7.2. POINT-OF-CARE TESTING

8. GLOBAL SEPSIS DIAGNOSTICS MARKET – REGIONAL OUTLOOK

8.1. NORTH AMERICA

8.1.1. MARKET BY TECHNOLOGY

8.1.2. MARKET BY DIAGNOSTIC METHOD

8.1.3. MARKET BY PRODUCT

8.1.4. MARKET BY PATHOGEN

8.1.5. MARKET BY TESTING TYPE

8.1.6. COUNTRY ANALYSIS

8.1.6.1. UNITED STATES

8.1.6.2. CANADA

8.2. EUROPE

8.2.1. MARKET BY TECHNOLOGY

8.2.2. MARKET BY DIAGNOSTIC METHOD

8.2.3. MARKET BY PRODUCT

8.2.4. MARKET BY PATHOGEN

8.2.5. MARKET BY TESTING TYPE

8.2.6. COUNTRY ANALYSIS

8.2.6.1. GERMANY

8.2.6.2. FRANCE

8.2.6.3. UNITED KINGDOM

8.2.6.4. ITALY

8.2.6.5. RUSSIA

8.2.6.6. SPAIN

8.2.6.7. REST OF EUROPE

8.3. ASIA-PACIFIC

8.3.1. MARKET BY TECHNOLOGY

8.3.2. MARKET BY DIAGNOSTIC METHOD

8.3.3. MARKET BY PRODUCT

8.3.4. MARKET BY PATHOGEN

8.3.5. MARKET BY TESTING TYPE

8.3.6. COUNTRY ANALYSIS

8.3.6.1. CHINA

8.3.6.2. JAPAN

8.3.6.3. INDIA

8.3.6.4. AUSTRALIA & NEW ZEALAND

8.3.6.5. SOUTH KOREA

8.3.6.6. ASEAN COUNTRIES

8.3.6.7. REST OF ASIA-PACIFIC

8.4. LATIN AMERICA

8.4.1. MARKET BY TECHNOLOGY

8.4.2. MARKET BY DIAGNOSTIC METHOD

8.4.3. MARKET BY PRODUCT

8.4.4. MARKET BY PATHOGEN

8.4.5. MARKET BY TESTING TYPE

8.4.6. COUNTRY ANALYSIS

8.4.6.1. MEXICO

8.4.6.2. BRAZIL

8.4.6.3. REST OF LATIN AMERICA

8.5. MIDDLE EAST AND AFRICA

8.5.1. MARKET BY TECHNOLOGY

8.5.2. MARKET BY DIAGNOSTIC METHOD

8.5.3. MARKET BY PRODUCT

8.5.4. MARKET BY PATHOGEN

8.5.5. MARKET BY TESTING TYPE

8.5.6. COUNTRY ANALYSIS

8.5.6.1. SAUDI ARABIA

8.5.6.2. UNITED ARAB EMIRATES

8.5.6.3. TURKEY

8.5.6.4. SOUTH AFRICA

8.5.6.5. REST OF MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

9.1. ABBOTT LABORATORIES

9.2. BECTON DICKINSON AND COMPANY (CR BARD)

9.3. BIOMERIEUX SA

9.4. BRUKER CORPORATION

9.5. CYTOSORBENTS

9.6. DANAHER CORPORATION

9.7. EKF DIAGNOSTICS

9.8. F HOFFMANN-LA ROCHE

9.9. IMMUNEXPRESS INC

9.10. LUMINEX CORPORATION

9.11. RESPONSE BIOMEDICAL CORPORATION

9.12. T2 BIOSYSTEMS INC

9.13. THERMO FISHER SCIENTIFIC INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1. OBJECTIVES OF STUDY

10.1.2. SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1. PRIMARY DATA SOURCES

10.2.2. SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1. EVALUATION OF PROPOSED MARKET

10.3.2. IDENTIFICATION OF DATA SOURCES

10.3.3. ASSESSMENT OF MARKET DETERMINANTS

10.3.4. DATA COLLECTION

10.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       GLOBAL SEPSIS DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       MARKET ATTRACTIVENESS INDEX

TABLE 3:       VENDOR SCORECARD

TABLE 4:       LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5:       LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 6:       LIST OF ACQUISITIONS & MERGERS

TABLE 7:       LIST OF NEW PRODUCT LAUNCHES

TABLE 8:       GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 9:       GLOBAL SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 10:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 11:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 12:     GRAM-NEGATIVE BACTERIA CAUSING SEPSIS

TABLE 13:     GRAM-POSITIVE BACTERIA CAUSING SEPSIS

TABLE 14:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

TABLE 15:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 16:     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 17:     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 18:     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 19:     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 20:     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 21:     NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

TABLE 22:     EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 23:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 24:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 25:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 26:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 27:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

TABLE 28:     ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 29:     ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 30:     ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 31:     ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 32:     ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 33:     ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

TABLE 34:     LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 35:     LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 36:     LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 37:     LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 38:     LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 39:     LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

TABLE 40:     MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 41:     MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 42:     MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 43:     MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 44:     MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 45:     MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     GLOBAL SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 3:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 4:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)

FIGURE 5:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 6:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 7:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)

FIGURE 8:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 9:     GLOBAL SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 10:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 11:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)

FIGURE 12:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)

FIGURE 13:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 14:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)

FIGURE 15:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 16:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 17:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)

FIGURE 18:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)

FIGURE 19:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 20:  GLOBAL SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 21:  GLOBAL SEPSIS DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 22:  UNITED STATES SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  CANADA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  GERMANY SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  FRANCE SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 26:  UNITED KINGDOM SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  ITALY SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  RUSSIA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  SPAIN SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  REST OF EUROPE SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 31:  CHINA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 32:  JAPAN SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 33:  INDIA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 34:  AUSTRALIA & NEW ZEALAND SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 35:  SOUTH KOREA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 36:  ASEAN COUNTRIES SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 37:  REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 38:  MEXICO SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 39:  BRAZIL SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 40:  REST OF LATIN AMERICA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 41:  SAUDI ARABIA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 42:  UNITED ARAB EMIRATES SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 43:  TURKEY SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 44:  SOUTH AFRICA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 45:  REST OF MIDDLE EAST & AFRICA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;